Monika Primon

423 total citations
8 papers, 111 citations indexed

About

Monika Primon is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Monika Primon has authored 8 papers receiving a total of 111 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Genetics and 2 papers in Immunology. Recurrent topics in Monika Primon's work include Ubiquitin and proteasome pathways (3 papers), Retinoids in leukemia and cellular processes (2 papers) and Protein Degradation and Inhibitors (2 papers). Monika Primon is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Retinoids in leukemia and cellular processes (2 papers) and Protein Degradation and Inhibitors (2 papers). Monika Primon collaborates with scholars based in United Kingdom, Slovenia and United States. Monika Primon's co-authors include Hardev Pandha, Richard Morgan, Helena Motaln, Matjaž Hren, Christian Schichor, Tamara T. Lah, Kristina Gruden, Ana Rotter, Keith D. Hunter and Guy R. Simpson and has published in prestigious journals such as Cancer Research, Scientific Reports and Experimental Cell Research.

In The Last Decade

Monika Primon

8 papers receiving 110 citations

Peers

Monika Primon

MB

GENET

ONCOL

CR

IMMUN

Maria Lugo-Fagundo United States

Yuchen Du United States

Dennis S. Metselaar Netherlands

Phuong M. Le United States

Lauren Heese United States

Peter‐Martin Bruch Germany

Kate Connor Ireland

Danielle Bozek Canada

Lily Chau United States

Dario Sterker Switzerland

Maria Lugo-Fagundo United States

Monika Primon

79 ×1.1

MB

24 ×0.8

GENET

24 ×1.0

ONCOL

38 ×1.7

CR

11 ×0.6

IMMUN

Citations per year, relative to Monika Primon Monika Primon (= 1×) peers Maria Lugo-Fagundo

Countries citing papers authored by Monika Primon

Since Specialization

Citations

This map shows the geographic impact of Monika Primon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monika Primon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monika Primon more than expected).

Fields of papers citing papers by Monika Primon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monika Primon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monika Primon. The network helps show where Monika Primon may publish in the future.

Co-authorship network of co-authors of Monika Primon

This figure shows the co-authorship network connecting the top 25 collaborators of Monika Primon. A scholar is included among the top collaborators of Monika Primon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monika Primon. Monika Primon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Morgan, Richard A., Monika Primon, Steven D. Shnyder, et al.. (2019). Abstract 5215: Targeting of HOX-PBX binding in glioblastoma multiforme as a novel therapeutic treatment. Cancer Research. 79(13_Supplement). 5215–5215. 1 indexed citations

2.

Primon, Monika, et al.. (2019). Membrane insertion and secretion of the Engrailed-2 (EN2) transcription factor by prostate cancer cells may induce antiviral activity in the stroma. Scientific Reports. 9(1). 5138–5138. 17 indexed citations

3.

Morgan, Richard, Monika Primon, Steven D. Shnyder, et al.. (2019). Abstract 5215: Targeting of HOX-PBX binding in glioblastoma multiforme as a novel therapeutic treatment. 5215–5215. 1 indexed citations

4.

Primon, Monika, Keith D. Hunter, Hardev Pandha, & Richard Morgan. (2019). Kinase Regulation of HOX Transcription Factors. Cancers. 11(4). 508–508. 21 indexed citations

5.

Primon, Monika, Peter C. Huszthy, Helena Motaln, et al.. (2017). Cathepsin L silencing increases As2O3 toxicity in malignantly transformed pilocytic astrocytoma MPA58 cells by activating caspases 3/7. Experimental Cell Research. 356(1). 64–73. 3 indexed citations

6.

Primon, Monika, et al.. (2016). HTL001, a novel inhibitor of HOX/PBX binding, is highly cytotoxic to prostate and breast cancer cells. European Journal of Cancer. 69. S133–S133. 4 indexed citations

7.

Primon, Monika, Peter C. Huszthy, Helena Motaln, et al.. (2013). Cathepsin L silencing enhances arsenic trioxide mediated in vitro cytotoxicity and apoptosis in glioblastoma U87MG spheroids. Experimental Cell Research. 319(17). 2637–2648. 20 indexed citations

8.

Motaln, Helena, Kristina Gruden, Matjaž Hren, et al.. (2012). Human Mesenchymal Stem Cells Exploit the Immune Response Mediating Chemokines to Impact the Phenotype of Glioblastoma. Cell Transplantation. 21(7). 1529–1545. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact